In today’s Pharmaceutical Executive Daily, the FDA introduces a PreCheck pilot program aimed at strengthening domestic manufacturing oversight, an ACIP member alleges FDA leadership halted a decision ...
On February 1, FDA announced a new pilot program designed to promote the construction of domestic manufacturing sites, along ...
According to public statements and social media posts from X, ACIP vice chair Robert Malone (a public ally of HHS secretary Robert F. Kennedy Jr.) publicly accused FDA Commissioner Marty Makary of ...
Eli Lilly is investing $3.5 billion in a new manufacturing facility in Lehigh Valley, Pennsylvania, to produce injectable ...
In today’s Pharmaceutical Executive Daily, Public Citizen files suit over undisclosed drug pricing agreements involving ...
Pharmaceutical Executive: What AI trends did you see at the 2026 JP Morgan Healthcare Conference? Angela Schwab: Good and bad. You see a lot of players coming into the market saying that they can do ...
When you can’t find specialized talent in the usual places, it undermines timelines for R&D, clinical trials, and commercialization. But there are other locations that employers can explore when ...
AstraZeneca entered a strategic collaboration with CSPC Pharmaceuticals to expand its weight management and metabolic disease ...
The deal underscores a broader shift in autoimmune drug development toward therapies that aim to reprogram disease-driving ...
The real “commercial launch” happens years before launch preparation officially begins. Once Phase III begins, your evidence ...
Teva's Honestly HD campaign, featuring Will Forte, aims to raise awareness about Huntington's disease through personal ...
In today’s Pharmaceutical Executive Daily, MJH Life Sciences CEO, Mike Hennessy Jr. examines why pharma and medtech still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results